Cogentix Medical

About:

Cogentix Medical products have increased treatment efficiency and lowered patient risk.

Website: http://www.cogentixmedical.com

Top Investors: Accelmed

Description:

Cogentix Medical products have increased treatment efficiency and lowered patient risk. Macroplastique® established the European market for bulking agents, EndoSheath® protective barrier redefined endoscopy and Urgent® PC set the standard for percutaneous tibial nerve stimulation (PTNS) as a treatment for Overactive Bladder. Cogentix Medical was formed in 2015 following a merger of Uroplasty and Vision-Sciences.

Total Funding Amount:

$25M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Minnesota City, Minnesota, United States

Founded Date:

1987-01-01

Contact Email:

customercare(AT)cogentixmedical.com

Founders:

Rob Kill

Number of Employees:

101-250

Last Funding Date:

2016-09-16

IPO Status:

Delisted

Industries: